{"id":26092,"date":"2026-08-03T13:22:07","date_gmt":"2026-08-03T08:22:07","guid":{"rendered":"https:\/\/usnews-14267fa.ingress-comporellon.ewp.live\/?p=26092"},"modified":"2026-08-03T13:22:07","modified_gmt":"2026-08-03T08:22:07","slug":"new-treatment-for-advanced-melanoma-uses-tumor-to-fight-the-disease","status":"publish","type":"post","link":"https:\/\/usnews-14267fa.ingress-comporellon.ewp.live\/?p=26092","title":{"rendered":"New treatment for advanced melanoma uses tumor to fight the disease"},"content":{"rendered":"<p><script>\r\n  atOptions = {\r\n    'key' : '644b717812d811d6a1c1fc5b6ccd6fa6',\r\n    'format' : 'iframe',\r\n    'height' : 90,\r\n    'width' : 728,\r\n    'params' : {}\r\n  };\r\n<\/script>\r\n<script src=\"https:\/\/www.highperformanceformat.com\/644b717812d811d6a1c1fc5b6ccd6fa6\/invoke.js\"><\/script>\r\n<br \/>\n<br \/>A  treatment for advanced melanoma that&#8217;s newly approved by the FDA is giving cancer patients new hope. Tumor-infiltrating lymphocyte, or &#8220;TIL&#8221; therapy, uses an individual&#8217;s own tumor to help fight the disease. CBS News&#8217; Natalie Brand reports.<br \/>\n<br \/><script async=\"async\" data-cfasync=\"false\" src=\"https:\/\/pl30214220.effectivecpmnetwork.com\/9ab3d4df8a7e1a6171e16ddbf732cc19\/invoke.js\"><\/script>\r\n<div id=\"container-9ab3d4df8a7e1a6171e16ddbf732cc19\"><\/div>\r\n<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A treatment for advanced melanoma that&#8217;s newly approved by the FDA is giving cancer patients new hope. Tumor-infiltrating lymphocyte, or &#8220;TIL&#8221; therapy, uses an individual&#8217;s own tumor to help fight the disease. CBS News&#8217; Natalie Brand reports.<\/p>\n","protected":false},"author":1,"featured_media":26093,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2026\/08\/03\/a9544c05-94fe-4332-b9d1-c11b6b200158\/thumbnail\/1200x630\/60872d033f7cb25a28c2560c037c1b77\/melanoma.jpg","fifu_image_alt":"","footnotes":""},"categories":[4],"tags":[],"class_list":["post-26092","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-hub"],"brizy_media":[],"_links":{"self":[{"href":"https:\/\/usnews-14267fa.ingress-comporellon.ewp.live\/index.php?rest_route=\/wp\/v2\/posts\/26092","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/usnews-14267fa.ingress-comporellon.ewp.live\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/usnews-14267fa.ingress-comporellon.ewp.live\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/usnews-14267fa.ingress-comporellon.ewp.live\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/usnews-14267fa.ingress-comporellon.ewp.live\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=26092"}],"version-history":[{"count":0,"href":"https:\/\/usnews-14267fa.ingress-comporellon.ewp.live\/index.php?rest_route=\/wp\/v2\/posts\/26092\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/usnews-14267fa.ingress-comporellon.ewp.live\/index.php?rest_route=\/wp\/v2\/media\/26093"}],"wp:attachment":[{"href":"https:\/\/usnews-14267fa.ingress-comporellon.ewp.live\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=26092"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/usnews-14267fa.ingress-comporellon.ewp.live\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=26092"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/usnews-14267fa.ingress-comporellon.ewp.live\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=26092"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}